Limited Functionality Warning

We are currently updating our network. During this time, certain functionality may be unavailable, including online orders. We apologize for any inconvenience this may cause you.

Please contact Customer Service with any questions.

Dr. Xuping Xie, University of Texas Medical Branch

NanoLuc® Luciferase Reporter Viruses

Dr. Xie’s group constructed a NanoLuc® SARS-CoV-2 reporter virus and screened a broad selection of existing anti-infective drugs. They identified several agents, including remdesivir, as potent, selective inhibitors of SARS-CoV-2. They also used the reporter virus to measure neutralizing antibody levels in COVID-19 patients.

Learn More

NanoLuc® Luciferase: One Enzyme, Endless Capabilities

Go to Technology Page

NanoLuc® Technologies Advance Virology Research

View Products